Effects of ischemic preconditioning on PDGF-BB expression in the gerbil hippocampal CA1 region following transient cerebral ischemia

Mol Med Rep. 2017 Aug;16(2):1627-1634. doi: 10.3892/mmr.2017.6799. Epub 2017 Jun 19.

Abstract

Ischemic preconditioning (IPC) is induced by exposure to brief durations of transient ischemia, which results in ischemic tolerance to a subsequent longer or lethal period of ischemia. In the present study, the effects of IPC (2 min of transient cerebral ischemia) were examined on immunoreactivity of platelet‑derived growth factor (PDGF)‑BB and on neuroprotection in the gerbil hippocampal CA1 region following lethal transient cerebral ischemia (LTCI; 5 min of transient cerebral ischemia). IPC was subjected to a 2‑min sublethal ischemia and a LTCI was given 5‑min transient ischemia. The animals in all of the groups were given recovery times of 1, 2 and 5 days and change in PDGF‑BB immunoreactivity was examined as was the neuronal damage/death in the hippocampus induced by LTCI. LTCI induced a significant loss of pyramidal neurons in the hippocampal CA1 region 5 days after LTCI, and significantly decreased PDGF‑BB immunoreactivity in the CA1 pyramidal neurons from day 1 after LTCI. Conversely, IPC effectively protected the CA1 pyramidal neurons from LTCI and increased PDGF‑BB immunoreactivity in the CA1 pyramidal neurons post‑LTCI. In conclusion, the results demonstrated that LTCI significantly altered PDGF‑BB immunoreactivity in pyramidal neurons in the hippocampal CA1 region, whereas IPC increased the immunoreactivity. These findings indicated that PDGF‑BB may be associated with IPC‑mediated neuroprotection.

MeSH terms

  • Animals
  • Becaplermin
  • CA1 Region, Hippocampal / immunology
  • CA1 Region, Hippocampal / metabolism*
  • CA1 Region, Hippocampal / pathology
  • Cell Death / physiology
  • Gerbillinae / metabolism*
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Immunohistochemistry
  • Ischemic Attack, Transient / metabolism*
  • Ischemic Attack, Transient / pathology
  • Ischemic Preconditioning / methods
  • Locomotion
  • Male
  • Neuroprotection
  • Proto-Oncogene Proteins c-sis / immunology
  • Proto-Oncogene Proteins c-sis / metabolism*
  • Pyramidal Cells / immunology
  • Pyramidal Cells / metabolism
  • Pyramidal Cells / pathology

Substances

  • Proto-Oncogene Proteins c-sis
  • Becaplermin